 |
|
|
|
Programme
|
|
|
Workshop organized by Health Technologies / Cell biology, development and evolution / Immunology, hematology, pneumology ITMOS of aviesan.
Scientific Organizing Committee: John De Vos, Annelise Bennaceur-Griscelli, Cécile Martinat, François Hirsch and Armelle Regnault
Tuesday, November 25th
ESC / iPS Similitudes and differences
|
|
10h00-10h30 |
|
Reprogramming human and non-human primate embryonic stem cells to ground state pluripotency - Pierre Savatier (SBRI, Lyon) |
|
10h30-11h00 |
|
X-chromosome inactivation in human pluripotent stem cells - Claire Rougeulle (Institut Epignétique, Paris) |
|
11h00-11h30 |
|
iPSC and Ageing - Jean-Marc Lemaitre (IGF, Montpellier) |
|
11h30-12h00 |
|
Lymphopoiesis modeling from hES cells - Rima Haddad (Inserm U967, U. Paris Sud, Fontenay aux Roses) |
|
12h00-12h30 |
|
Christine Baldeschi (Nice) |
|
|
|
|
|
12h30 - 14h |
|
Lunch |
National iPSC Infrastructure
|
|
14h-14h30 |
|
INGESTEM Large scale ipSC and International pluripotent stem cell Initiatives - Annelise Bennaceur (AP-HP, Inserm) |
Production of iPS
|
|
14h30-14h50 |
|
Critical issues to produce GMP iPS cells - John De Vos (IRB, Montpellier) |
|
14h50-15h10 |
|
CRISPR: genome engineering made easy - Olivier Féraud (ESTeam, Paris) |
|
15h10-15h30 |
|
Bioprocessing of human pluripotent stem cells - Yacine Laabi (I Stem) |
Ethical, legislative and regulatory situation
|
|
15h30-16h00 |
|
Ethics - Laure Coulombel (Agence de la Biomédecine) |
|
16h00-16h30 |
|
EU support to stem cell research - Charles Kessler (Principal Scientific Officer, DGRI, European Commission) |
|
|
|
|
|
16h30-17h00 |
|
Coffee break |
Stem cells & Biomaterials
|
|
17h00-17h30 |
|
3D scaffolds for stem cells in vitro and in vivo - Didier Letourneur (LVTS, Paris) |
|
17h30-18h00 |
|
Hematopoietic stem cell differentiation into platelet-producing megakaryocytes - Dominique Baruch (Inserm, Paris) |
iPS for drug screening
|
|
18h00-18h30 |
|
Screening for neurogenesis modifiers using PSC-derived neuronal progenitors - Alexandra Benchoua (CECS/Istem, Evry) |
|
18h30-19h00 |
|
Development of highly selective SMN2 splicing modifiers to find a therapy for spinal muscular atrophy - Friedrich Metzer (Roche Innovation Center, Basel) |
|
|
|
|
|
20h |
|
Dinner |
Wednesday, November 26th
iPS as diseases and gene therapy models
|
|
9h00-9h30 |
Myeloproliferative disorders - Ali Turhan (Inserm, Le Kremlin Bicêtre) |
|
9h30-10h00 |
Lentiviral globin gene transfer in beta-thalassemia iPS cell model - Leila Maouche-Chrétien (Inserm, Fontenay-aux-Roses) |
|
10h00-10h30 |
Proof of concept for gene therapy in iPSC-derived retinal pigment epithelium from patients - Viki Kalatzis (INM, Montpellier) |
|
10h30-11h00 |
Use of human pluripotent stem cells for neuromuscular diseases - Cécile Martinat (Istem, Evry) |
|
|
|
11h-11h20 |
Coffee break |
|
|
|
|
11h20-11h50 |
iPS to model neurodegenerative disorders - Delphine Bohl (ICM, Paris) |
|
11h50-12h20 |
iPSC as a cellular model for epithelial physiopathology - Daniel Aberdam (Inserm, St Louis) |
|
12h20-12h50 |
When neurodevelopment meets neurodegeneration: patient iPSC derived neurons to study a rare disorder - Matthias Groszer (Inserm) |
|
|
|
|
12h50-14h00 |
Lunch |
iPS use (autologous and allogenic)
|
|
14h00-14h30 |
Red blood cells from stem cells in vitro: perspectives for transfusion medicine - Luc Douay (Saint-Antoine, Paris) |
|
14h30-15h00 |
Strategies working towards gene/cell therapy of liver diseases - Anne Dubart-Kupperschmitt (Inserm, Paul Brousse) |
|
15h00-15h30 |
Optimized generation of neutrophils and macrophages from iPSC to model Chronic Granulomatous Disease - Marie José Stasia-Pauger (CNRS, UMR 5525, Université J. Fourier, Grenoble) |
|
|
|
|
15h30-16h00 |
Coffee break |
|
|
|
|
16h00-16h30 |
New type of endodermic stem cells for pancreatic and hepatic regeneration - Frank Griscelli (Inserm, Paris V) |
|
16h30-17h00 |
Using human pluripotent stem cells to treat retinal disease - Olivier Goureau (Institut de la vision, Paris) |
The end
|
|
|
|
|
|
|
|
 |
|
|
|
|
|
|
